Association between genetic polymorphism of tumor necrosis factor-α and risk of oral submucous fibrosis, a pre-cancerous condition of oral cancer

被引:52
作者
Chiu, CJ
Chiang, CP
Chang, ML
Chen, HM
Hahn, LJ
Hsieh, LL
Kuo, YS
Chen, CJ
机构
[1] Natl Taiwan Univ, Grad Inst Epidemiol, Coll Publ Hlth, Taipei 10018, Taiwan
[2] Natl Taiwan Univ, Sch Dent, Coll Med, Taipei 10018, Taiwan
[3] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan
[4] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan 333, Taiwan
关键词
oral submucous fibrosis; tumor necrosis factor-alpha;
D O I
10.1177/00220345010800120601
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Many cytokines have been thought to play important roles in the pathogenesis of oral submucous fibrosis (OSF), an areca nut chewing-specific pre-cancerous condition characterized by the deposition of collagen in oral submucosa. Tumor necrosis factor-alpha (TNF-alpha), situated in the class III region of human leukocyte antigen (HLA), is a mediator with multiple functions, including the regulation of inflammatory reaction and transcriptions of collagen and collagenase. In total, 809 male subjects were recruited for assessment of the association of OSF with a bi-allelic promoter-region (-308) polymorphism on the TNFA gene. The high production allele, TNF2, was significantly lower among OSF subjects (n = 166) than in areca-chewing controls (n = 284). This association was independent of oral cancer status. The multivariate-adjusted odds ratio for the TNFA 11 genotype was 2.6 (95% confidence interval = 1.4-4.9; p = 0.004). The finding may imply a multifunctional etiological factor of TNF-alpha in OSF pathogenesis.
引用
收藏
页码:2055 / 2059
页数:5
相关论文
共 36 条
[1]   TUMOR-NECROSIS-FACTOR RECEPTOR SUPERFAMILY MEMBERS AND THEIR LIGANDS [J].
ARMITAGE, RJ .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (03) :407-413
[2]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[3]   PROLONGED ACTIVATION OF JUN AND COLLAGENASE GENES BY TUMOR NECROSIS FACTOR-ALPHA [J].
BRENNER, DA ;
OHARA, M ;
ANGEL, P ;
CHOJKIER, M ;
KARIN, M .
NATURE, 1989, 337 (6208) :661-663
[4]  
CANNIFF JP, 1985, TISSUE ANTIGENS, V26, P138
[5]   ORAL SUBMUCOUS FIBROSIS - ITS PATHOGENESIS AND MANAGEMENT [J].
CANNIFF, JP ;
HARVEY, W ;
HARRIS, M .
BRITISH DENTAL JOURNAL, 1986, 160 (12) :429-434
[6]   LINKAGE MAP OF THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX INCLUDING THE TUMOR-NECROSIS-FACTOR GENES [J].
CARROLL, MC ;
KATZMAN, P ;
ALICOT, EM ;
KOLLER, BH ;
GERAGHTY, DE ;
ORR, HT ;
STROMINGER, JL ;
SPIES, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8535-8539
[7]   Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region [J].
Gordon, MA ;
Oppenheim, E ;
Camp, NJ ;
di Giovine, FS ;
Duff, GW ;
Gleeson, D .
JOURNAL OF HEPATOLOGY, 1999, 31 (02) :242-247
[8]  
Gupta PC, 1998, NATL MED J INDIA, V11, P113
[9]   Interferon gamma (IFN-γ) may reverse oral submucous fibrosis [J].
Haque, MF ;
Meghji, S ;
Nazir, R ;
Harris, M .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2001, 30 (01) :12-21
[10]   An immunohistochemical study of oral submucous fibrosis [J].
Haque, MF ;
Harris, M ;
Meghji, S ;
Speight, PM .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1997, 26 (02) :75-82